F&P Healthcare lifts guidance

CLAIRE ROGERS
Last updated 09:59 22/11/2012

Relevant offers

National business

Shamubeel Eaqub: 2017, welcome to the era of populism Markets 'cautious' but US stocks climb after US President Donald Trump's inauguration NZ's waning sheep flock: Has our pastoral identity finally jumped the fence? Pooches at the pub: Hamilton's The Keg Room offers a specially-prepared menu for dogs 1MBD scandal: Judge allows Malaysian businessman tussling for $370m in seized assets to take control of NZ trusts Mark Hotchin returns to New Zealand but critics say Hanover investors unlikely to forgive Fashbae founder Bridget Thrackwray Kiwi gardening company defends 'Black Magic' product amid racism concerns Schools' 'BYOD' or 'Bring your own device' demands are a rising cost to parents While 146-year-old US circus closes, the show goes on in New Zealand

Fisher & Paykel Healthcare has boosted its full-year earnings guidance after a strong first half that saw net profit jump 18 per cent year-on-year to $33.3 million.

The company, which is listed on the NZX and the ASX and makes medical equipment such as sleep apnoea masks, said it now expected full year net profit to be between $69m and $72m. That was an increase of $3m to $4m on guidance given at its annual general meeting in August.

FPH said the strong first half result was down to revenue growth, improved gross margins and operating efficiencies.

Operating revenue in the company's respiratory and acute care division rose 11 per cent, driven by increasing acceptance of its respiratory humidification systems and revenue from new products.

Revenue for its obstructive sleep apnoea range rose by 3 per cent - when exchange rate fluctuations were excluded, thanks in part to the success of its new nasal pillows and nasal masks.

Chief executive Michael Daniell said it expected constant currency revenue growth to increase further in the second half of the year - the six months to March 31 - as new products and applications continued to gain traction.

FPH declared an interim dividend of 5.4 cents per share. Its shares are currently priced on the NZX at $2.44.

The company reported a flat full-year net profit of $64.1m for the year ending March 31 2012, blaming the stagnant result on the volatile New Zealand dollar.

Ad Feedback

- BusinessDay.co.nz

Special offers

Featured Promotions

Sponsored Content